Russell Investments Group
FBLG icon

Russell Investments Group’s FibroBiologics FBLG Stock Holding History

Russell Investments Group’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-269
Closed -$10.8K – 3888
2024
Q4 		$10.8K Buy
269
+266
+8,867% +$14.3K ﹤0.01% 3117
2024
Q3 		$204 Buy
+3
New +$199 ﹤0.01% 3630

Other funds holding FBLG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAS
Optivise Advisory Services Franklin, Tennessee $197M AUM 26.07% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Russell Investments Group's FBLG Position: Q1 2025 in Review

Russell Investments Group sold out of FibroBiologics (FBLG) in Q1 2025, closing a stake of 269 shares — an estimated $10.8K sold.

Russell Investments Group first reported a position in FBLG in Q3 2024 and held it in 2 quarters. The position peaked at $10.8K in Q4 2024. 65 funds tracked by Wall St. Rank hold FBLG as of Q1 2025.

  • Russell Investments Group reported no remaining FibroBiologics position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 269 FibroBiologics shares in Q1 2025, an estimated $10.8K.
  • Russell Investments Group first reported a position in FibroBiologics in Q3 2024 and held it in 2 quarters.
  • Russell Investments Group's FibroBiologics position peaked at $10.8K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.